Literature DB >> 19841456

Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study.

Reimar W Thomsen1, W Marieke Schoonen, Dóra K Farkas, Anders Riis, Jacob Jacobsen, Jon P Fryzek, Henrik Toft Sørensen.   

Abstract

BACKGROUND: Splenectomy has been associated with increased risk for infection.
OBJECTIVE: To assess the magnitude and duration of risk for hospital contact with infection associated with splenectomy.
DESIGN: Population-based cohort study.
SETTING: Denmark. PATIENTS: All 3812 persons in Denmark who underwent splenectomy from 1996 to 2005. Splenectomized patients were matched to 3 comparison cohorts: the general population, appendectomized patients, and unsplenectomized patients with indications for splenectomy. MEASUREMENTS: Relative risks were assessed for hospital contact involving any infection, pneumonia, and microbiologically confirmed bacteremia among 3812 splenectomized patients and their matched comparisons, during different follow-up periods and after regression analysis for confounder adjustment.
RESULTS: The adjusted relative risk for any hospital contact with infection was highest within 90 days of splenectomy: 10.2% vs. 0.6% among general population comparisons (adjusted odds ratio, 18.1 [95% CI, 14.8 to 22.1]) and 10.2% vs. 4.2% among appendectomized patients (adjusted odds ratio, 2.4 [CI, 2.1 to 2.8]). The hazard of infection was 4.6-fold (CI, 3.8 to 5.5) higher in splenectomized patients than in general population comparisons from 91 to 365 days after splenectomy and 2.5 times (CI, 2.2 to 2.8) higher more than 365 days after splenectomy. The risks were similar for pneumonia and were higher for bacteremia. Markedly increased risks were also found when compared with those of appendectomized patients. Modest increases in infection risk were seen with splenectomy matched-indication comparisons (adjusted 90-day odds ratio, 1.7 [CI, 1.5 to 2.1]; hazard ratios, 1.5 [CI, 1.2 to 1.8] from 91 to 365 days after splenectomy and 1.2 [CI, 1.1 to 1.4] beyond 365 days after splenectomy). Relative risks for infection were highest in patients who had splenectomy because of hematologic disorders. LIMITATION: Increased surveillance among splenectomized patients may have affected the findings.
CONCLUSION: Splenectomy is associated with increased long-term risk for infections involving hospital contact.

Entities:  

Mesh:

Year:  2009        PMID: 19841456     DOI: 10.7326/0003-4819-151-8-200910200-00008

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  31 in total

1.  Altered gene expression in the spleen of adolescent rats following high ethanol concentration binge drinking.

Authors:  Xiangqian Liu; Xin Mao; Sulie L Chang
Journal:  Int J Clin Exp Med       Date:  2011-10-11

2.  The effect of rituximab on vaccine responses in patients with immune thrombocytopenia.

Authors:  Ishac Nazi; John G Kelton; Mark Larché; Denis P Snider; Nancy M Heddle; Mark A Crowther; Richard J Cook; Alan T Tinmouth; Joy Mangel; Donald M Arnold
Journal:  Blood       Date:  2013-07-12       Impact factor: 22.113

Review 3.  How I treat autoimmune lymphoproliferative syndrome.

Authors:  V Koneti Rao; João Bosco Oliveira
Journal:  Blood       Date:  2011-09-01       Impact factor: 22.113

4.  [Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].

Authors:  Ingrid Pabinger; Günther Gastl; Michael Steurer; Siegfried Sormann; Michael Fillitz; Josef Friedl; Dietmar Geissler; Klaus Geissler; Richard Greil; Paul Knöbl; Sibylle Kozek-Langenecker; Peter Krippl; Paul Kyrle; Alois Lang; Werner Linkesch; Heinz Ludwig; Markus Müller; Simon Panzer; Elisabeth Pittermann; Josef Thaler; Ansgar Weltermann
Journal:  Wien Klin Wochenschr       Date:  2012-03-03       Impact factor: 1.704

5.  Outcomes after splenectomy in children: a 48-year population-based study.

Authors:  Mohammad A Khasawneh; Nicolas Contreras-Peraza; Matthew C Hernandez; Christine Lohse; Donald H Jenkins; Martin D Zielinski
Journal:  Pediatr Surg Int       Date:  2019-02-02       Impact factor: 1.827

Review 6.  Splenectomy for immune thrombocytopenia: down but not out.

Authors:  Shruti Chaturvedi; Donald M Arnold; Keith R McCrae
Journal:  Blood       Date:  2018-01-02       Impact factor: 22.113

7.  Clinical spectrum of serious bacterial infections among splenectomized patients with hemoglobinopathies in Israel: a 37-year follow-up study.

Authors:  W Sakran; C Levin; Y Kenes; R Colodner; A Koren
Journal:  Infection       Date:  2011-08-25       Impact factor: 3.553

Review 8.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

9.  Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy.

Authors:  Karen K W Wang; Cathy Charles; Nancy M Heddle; Emmy Arnold; Laura Molnar; Donald M Arnold
Journal:  Health Expect       Date:  2012-08-07       Impact factor: 3.377

Review 10.  Positioning new treatments in the management of immune thrombocytopenia.

Authors:  Donald M Arnold
Journal:  Pediatr Blood Cancer       Date:  2012-10-25       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.